Literature DB >> 23510764

Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.

S de Sanjosé, B Serrano, X Castellsagué, M Brotons, J Muñoz, L Bruni, F X Bosch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23510764     DOI: 10.1016/S0264-410X(12)01435-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  32 in total

1.  Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.

Authors:  Sabrina H Tsang; Partha Basu; Noemi Bender; Rolando Herrero; Troy J Kemp; Aimée R Kreimer; Martin Müller; Gitika Panicker; Michael Pawlita; Ligia A Pinto; Joshua N Sampson; Rengaswamy Sankaranarayanan; John Schussler; Peter Sehr; Monica S Sierra; Elizabeth R Unger; Tim Waterboer; Allan Hildesheim
Journal:  Vaccine       Date:  2020-07-24       Impact factor: 3.641

2.  Development of a highly thermostable, adjuvanted human papillomavirus vaccine.

Authors:  Kimberly J Hassett; Natalie M Meinerz; Florian Semmelmann; Megan C Cousins; Robert L Garcea; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2015-05-18       Impact factor: 5.571

3.  Precancerous Lesions of the Cervix and Associated Factors among Women of East Gojjam, Northwest Ethiopia, 2020.

Authors:  Mamaru Getinet; Molla Taye; Abebe Ayinalem; Menberesibhat Gitie
Journal:  Cancer Manag Res       Date:  2021-12-29       Impact factor: 3.989

4.  Prevalence of cervical human papillomavirus in Mexico, 2010-2017: analysis of 2.7 million women.

Authors:  Erika Hurtado-Salgado; Eduardo Ortiz-Panozo; Jorge Salmerón; Rufino Luna-Gordillo; Betania Allen-Leigh; Nenetzen Saavedra-Lara; Eduardo L Franco; Eduardo Lazcano-Ponce
Journal:  Cancer Causes Control       Date:  2022-10-22       Impact factor: 2.532

5.  Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.

Authors:  Fanling Meng; Shu Tan; Tianbo Liu; Hongtao Song; Ge Lou
Journal:  Tumour Biol       Date:  2015-11-02

6.  Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania.

Authors:  Melissa S Cunningham; Emily Skrastins; Ryan Fitzpatrick; Priya Jindal; Olola Oneko; Karen Yeates; Christopher M Booth; Jennifer Carpenter; Kristan J Aronson
Journal:  BMJ Open       Date:  2015-03-10       Impact factor: 2.692

7.  Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: Community-based cross-sectional study.

Authors:  Yitagesu Habtu Aweke; Samuel Yohannes Ayanto; Tariku Laelago Ersado
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

8.  Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy.

Authors:  Francesco Saverio Mennini; Paolo Bonanni; Florence Bianic; Chiara de Waure; Gianluca Baio; Giacomo Plazzotta; Mathieu Uhart; Alessandro Rinaldi; Nathalie Largeron
Journal:  Cost Eff Resour Alloc       Date:  2017-07-11

9.  Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda.

Authors:  Jean Damascène Makuza; Sabin Nsanzimana; Marie Aimee Muhimpundu; Lydia Eleanor Pace; Joseph Ntaganira; David James Riedel
Journal:  Pan Afr Med J       Date:  2015-09-11

10.  A Public Health Priority: Disparities in Gynecologic Cancer Research for African-Born Women in the United States.

Authors:  Leeya F Pinder; Brett D Nelson; Melody Eckardt; Annekathryn Goodman
Journal:  Clin Med Insights Womens Health       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.